Discovery Life Sciences hosted an Exclusive Lunchtime Networking Event: Unlocking Biomarker Potential for Maximum Impact: Leveraging Health Institute Status and Multi-omic Approaches
This event was meticulously crafted for biopharma professionals dedicated to advancing biomarker discovery, development, and implementation. Attendees gained unparalleled insights ready for real-world application, made valuable connections, and explored novel strategies tailored to the evolving demands of biomarker science.
Missed it? You can still benefit from the discussion- Watch the event on demand here:
Featured Speakers:
Jane Theaker, Precision Medicine and Diagnostics Expert, CEO Destina Genomics, Chair of Invenirex
Donald A. Skifter, Ph.D, Senior Vice President, Scientific Affairs, Discovery Life Sciences
Annette Muehleisen, Ph.D. Director, Genomics, Discovery Life Sciences
Huw Ricketts, Senior Director, CLIA Business Development, QIAGEN